Ischemic Cerebral Stroke Prevention Therapeutics Market: Opportunities and Forecast Assessment, 2017 - 2027
Future Market Insights has announced the addition of the “Ischemic Cerebral Stroke Prevention Therapeutics Market: Global Industry Analysis and Opportunity Assessment 2017-2027" report to their offering.
Future Market Insights has announced the addition of the “Ischemic Cerebral Stroke Prevention Therapeutics Market: Global Industry Analysis and Opportunity Assessment 2017-2027" report to their offering.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Ischemic</strong> <strong>Cerebral</strong> <strong>Stroke</strong> <strong>Prevention</strong> <strong>Therapeutics</strong><br />
<strong>Market</strong><br />
April <strong>2017</strong><br />
Report Id : REP-GB-3236<br />
Status : Ongoing<br />
Category : Healthcare, Pharmaceuticals & Medical Devices<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved
About<br />
Future <strong>Market</strong> Insights<br />
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom<br />
research reports, <strong>and</strong> consulting services. We deliver a complete packaged solution, which<br />
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth<br />
insights, aerial view of the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC,<br />
ASEAN, <strong>and</strong> BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,<br />
Technology, Healthcare, <strong>and</strong> Retail.<br />
We have a global presence with delivery centers across India specializing in providing global<br />
research reports <strong>and</strong> country research reports. FMI is headquartered out of London, U.K., with a<br />
state-of-the-art delivery center located in Pune, India. We combine our knowledge <strong>and</strong> learning<br />
from every corner of the world to distill it to one thing – the perfect solution for our client.<br />
Research Capabilities<br />
Sector Coverage<br />
<br />
<br />
<br />
<br />
Customized Research<br />
Syndicated Research<br />
Investment Research<br />
Social Media Research<br />
<br />
<br />
<br />
<br />
Automotive <strong>and</strong> Transportation<br />
Electronics, Semiconductor, <strong>and</strong> ICT<br />
Retail <strong>and</strong> Consumer Products<br />
Industrial Automation <strong>and</strong> Equipment<br />
<br />
<br />
<br />
<br />
Chemicals & Materials<br />
Food <strong>and</strong> Beverages<br />
Services <strong>and</strong> Utilities<br />
Energy, Mining, Oil, <strong>and</strong> Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
2
Research Methodology (1/2)<br />
Systematic Research Approach<br />
<strong>Market</strong> profiling<br />
Formulating discussion guide<br />
Developing list of respondents<br />
Data collection<br />
Data validation<br />
4<br />
5<br />
3<br />
1<br />
2<br />
In-depth secondary research is used to<br />
ascertain overall market size, top<br />
industry players, top products, industry<br />
associations, etc.<br />
PMR formulates a detailed discussion<br />
guide to conduct expert <strong>and</strong> industry<br />
interviews<br />
PMR develops a list of industry players<br />
(manufacturers), distributors, retailers<br />
<strong>and</strong> industry experts<br />
PMR conducts interviews with industry<br />
experts, industry players, distributors<br />
<strong>and</strong> retailers<br />
Data is validated by triangulation<br />
method, wherein secondary, primary<br />
<strong>and</strong> PMR analysis contribute to the final<br />
data<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Data<br />
Collection<br />
Data Filter<br />
& Analysis<br />
Identifying key opinion leaders<br />
Questionnaire design<br />
In-depth interviews<br />
Coverage across value chain<br />
<strong>Market</strong> participants<br />
Key strengths<br />
Product portfolio<br />
Mapping as per value chain<br />
Key focus segments<br />
A<br />
Primary<br />
Research<br />
C<br />
Company<br />
Analysis<br />
Research &<br />
Intelligence<br />
SOLUTION<br />
Actionable<br />
Insights<br />
B<br />
Desk<br />
Research<br />
<br />
<br />
<br />
<br />
<br />
<br />
Business<br />
Solution<br />
Key industry experts<br />
Channel study<br />
Developments<br />
<strong>Market</strong> dynamics<br />
Products<br />
Conclusions<br />
Data analysis<br />
6<br />
Data is scrutinized using MS-Excel to<br />
obtain qualitative <strong>and</strong> quantitative<br />
insights about the industry<br />
Primary Research #<br />
Secondary Research #<br />
Paid Publications#<br />
Insights<br />
7<br />
PMR delivers industry insights <strong>and</strong><br />
information in the required format<br />
(PDF)<br />
<br />
<br />
<br />
<br />
Linkedin<br />
Zoominfo<br />
Salesforce<br />
Avention<br />
<br />
<br />
<br />
<br />
Company websites<br />
Company annual<br />
reports<br />
White papers<br />
Financial reports<br />
<br />
<br />
<br />
<br />
Factiva<br />
GBI<br />
Genios<br />
Meltwater<br />
# includes sources of databases<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
3
<strong>Ischemic</strong> <strong>Cerebral</strong> <strong>Stroke</strong> <strong>Prevention</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
When an obstruction occurs in the blood vessel that supplies blood to the brain, it is known as ischemic<br />
stroke. This stroke accounts for around 87 percent of the total stroke cases <strong>and</strong> the main cause leading to<br />
ischemic stroke is uncontrolled hypertension. Basically, ischemic stroke is due to weak blood vessel,<br />
which gets rupture <strong>and</strong> leads to blood spill into the brain tissue. There are two types of ischemic cerebral<br />
strokes namely embolic or thrombotic. During atherosclerosis, when artery is blocked by a blood clot,<br />
resulting into fatty deposits. However, when a blood clot is formed outside the brain <strong>and</strong> then travels to<br />
the blood stream, it is known as embolus (emboli) stroke. Globally, technological advancements leading<br />
to development of advanced surgical devices coupled with increasing prevalence of ischemic strokes<br />
among people has led to dem<strong>and</strong> for better <strong>and</strong> efficient stroke management or treatment. Major goal of<br />
ischemic cerebral stroke prevention to restore flow of blood as quickly as possible. Conventional ischemic<br />
stroke treatments include intravenous thrombolytic therapy <strong>and</strong> intra-arterial mechanical thrombectomy,<br />
which includes stent retriever devices. According to American <strong>Stroke</strong> Association, few recommendations<br />
related to prevention of ischemic cerebral stroke include sleep apnea screening, smoking cessation, <strong>and</strong><br />
usage of anticoagulants orally especially patients suffering with non-valvular atrial fibrillation.<br />
It is essential to prevent the stroke as this is the deadly condition <strong>and</strong> is an age related. This can be<br />
basically controlled in two ways, Primary <strong>Prevention</strong> of <strong>Stroke</strong> <strong>and</strong> the other is Secondary <strong>Prevention</strong> of<br />
<strong>Stroke</strong>.<br />
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3236<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 4
<strong>Ischemic</strong> <strong>Cerebral</strong> <strong>Stroke</strong> <strong>Prevention</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
Primary <strong>Prevention</strong> of <strong>Stroke</strong> can be done with the administration of antihypertensive drugs,<br />
anticoagulants-warfarin; antiplatelet agents, <strong>and</strong> statins. The prominent cause of <strong>Ischemic</strong> <strong>Cerebral</strong><br />
<strong>Stroke</strong> are smoking, hypertension, Diabetes, Sickle cell disease, Body fat etc. There are also some home<br />
primary remedies like self-monitoring of blood pressure in hypertensive patients <strong>and</strong> proper sleep.<br />
<strong>Ischemic</strong> <strong>Cerebral</strong> <strong>Stroke</strong> <strong>Prevention</strong> <strong>Therapeutics</strong> <strong>Market</strong>: Drivers <strong>and</strong> Restraints<br />
Increase in the number of cerebral stroke cases across the globe coupled with high prices for AIS therapy<br />
contribute towards significant growth of ischemic cerebral stroke prevention therapeutics market<br />
worldwide. In addition, growing prevalence of acute ischemic strokes among young population is<br />
anticipated to fuel the dem<strong>and</strong> for surgical procedures, thereby in order to avoid the surgery dem<strong>and</strong> for<br />
ischemic cerebral stroke prevention therapeutics will grow significantly in the next five to six years.<br />
However, limited availability of efficient drugs is restricting the market growth. Also, ischemic attack<br />
survivors are prone to another attack, thereby increased morbidity <strong>and</strong> mortality. This is leading to<br />
increased concerns for prevention therapeutics, resulting in overall ischemic cerebral stroke prevention<br />
therapeutics market growth.<br />
Visit for TOC@ http://www.futuremarketinsights.com/toc/rep-gb-3236<br />
<strong>Ischemic</strong> <strong>Cerebral</strong> <strong>Stroke</strong> <strong>Prevention</strong> <strong>Therapeutics</strong> <strong>Market</strong>: Segmentation<br />
The global market for ischemic cerebral stroke prevention therapeutics is broadly classified on the basis<br />
of drug type, <strong>and</strong> end user.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 5
<strong>Ischemic</strong> <strong>Cerebral</strong> <strong>Stroke</strong> <strong>Prevention</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
Based on drug type, the ischemic cerebral stroke prevention therapeutics market has been segmented<br />
as follows:<br />
Anticoagulation Therapy<br />
‣ Warfarin<br />
‣ Heparin<br />
Revascularization<br />
Reperfusion<br />
‣ Eminase<br />
‣ Retavase<br />
‣ Streptase<br />
‣ Others<br />
Full Report Analysis@ http://www.futuremarketinsights.com/reports/ischemic-cerebral-stroke<br />
prevention-therapeutics-market<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 6
<strong>Ischemic</strong> <strong>Cerebral</strong> <strong>Stroke</strong> <strong>Prevention</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
Antiplatelet<br />
‣ Aspirin<br />
‣ Clopidogrel<br />
‣ Dipyridamole<br />
‣ Ticlopidine<br />
Neuroprotective<br />
‣ Acetyl-L-carnitine<br />
‣ Citicoline (CDP-Choline)<br />
‣ Others<br />
Based on end user, theischemic cerebral stroke prevention therapeutics market has been segmented as<br />
follows:<br />
Hospitals<br />
Clinics<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 7
<strong>Ischemic</strong> <strong>Cerebral</strong> <strong>Stroke</strong> <strong>Prevention</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
Palliative Care<br />
Ambulatory Surgery Centers<br />
<strong>Ischemic</strong> <strong>Cerebral</strong> <strong>Stroke</strong> <strong>Prevention</strong> <strong>Therapeutics</strong> <strong>Market</strong>: Overview<br />
The global ischemic cerebral stroke prevention therapeutics market is expected to exp<strong>and</strong> at healthy<br />
CAGR owing to increasing awareness for prevention of ischemic cerebral strokes prevention across the<br />
world. Among end users, hospital end user segment is expected to account for maximum share due to<br />
requirement of advanced healthcare infrastructure <strong>and</strong> low cost.<br />
<strong>Ischemic</strong> <strong>Cerebral</strong> <strong>Stroke</strong> <strong>Prevention</strong> <strong>Therapeutics</strong>: Region-wise Outlook<br />
Geographically, the global intravenous ultrasound systems market is classified into regions namely, North<br />
America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East <strong>and</strong> Africa.<br />
Among all the regions, North America will continue to lead the global market for ischemic cerebral stroke<br />
prevention therapeutics. This is attributed to increasing cerebral stroke cases in the region. Geriatric<br />
population in Europe <strong>and</strong> Asia Pacific, who are prone to cerebral stroke offer opportunity for ischemic<br />
cerebral stroke prevention therapeutics market in the regions.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 8
<strong>Ischemic</strong> <strong>Cerebral</strong> <strong>Stroke</strong> <strong>Prevention</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
<strong>Ischemic</strong> <strong>Cerebral</strong> <strong>Stroke</strong> <strong>Prevention</strong> <strong>Therapeutics</strong>: Key Players<br />
Key players operating in the global intravenous ultrasound systems market are Johnson & Johnson<br />
(Cordis Corporation), Boston <strong>Therapeutics</strong>, Inc., Edge <strong>Therapeutics</strong>, Inc., Zocere, Inc., Lundbeck,<br />
ThromboGenics, Vernalis, Bayer, Bristol-Myers Squibb, <strong>and</strong> Boehringer Ingelheim.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 9
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
For media queries, contact the press office at<br />
press@futuremarketinsights.com<br />
For other queries contact:<br />
Harish Tiwari<br />
(General Manager & Global Head Business Development)<br />
Future <strong>Market</strong> Insights: 3rd Floor,<br />
207 Regent Street, London W1B 3HH<br />
T: +44 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
Thank You<br />
Future <strong>Market</strong> Insights Global & Consulting Private Limited (FMI)<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
10
Change language